Survival Motor Neuron proteins (SMN1 and SMN2) required for efficient assembly of small nuclear ribonucleoprotein (snRNP) complexes are encoded by nearly identical telomeric and centromeric forms of SMN gene respectively. Both the SMN1 and SMN2 genes express SMN protein, however, the amount of functional full-length protein produced by SMN2 is much less than that produced by SMN1 due to the alternative splicing.The SMN gene is constitutively expressed in wide variety of tissues including brain, kidney, liver and spinal cord, while motor neurons are particularly vulnerable to reduced SMN protein levels. Deletion or mutational inactivation of the SMN1 gene causes spinal muscular atrophy (SMA), a lethal genetic disease characterized by loss of motor neurons in the spinal cord. The absence of SMN1 can be partially compensated for by SMN2 and the SMN2 expression level is associated with SMA severity. Accurately measurement of SMN2 protein level may be used as an early 'biomarker' for assessing SMA treatment effect. This kit is for the quantitative determination of SMN2 level in vivo.